about
Effects of host and virus related factors on interferon-α+ribavirin and pegylated-interferon+ribavirin treatment outcomes in chronic Hepatitis C patients.Antiviral activity of Acacia nilotica against Hepatitis C Virus in liver infected cellsAlanine aminotransferase elevation during peginterferon alpha-2a or alpha-2b plus ribavirin treatmentHepatitis C comorbidities affecting the course and response to therapyRole of hematopoietic growth factors as adjuncts in the treatment of chronic hepatitis C patients.
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@ast
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@en
type
label
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@ast
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@en
prefLabel
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@ast
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@en
P2860
P356
P1476
Peginterferon-alpha2a (40 kDa) for chronic hepatitis C.
@en
P2093
George V Papatheodoridis
Stephanos J Hadziyannis
P2860
P304
P356
10.1517/14656566.4.4.541
P407
P577
2003-04-01T00:00:00Z